Molecular Mechanisms of Class Switch Recombination

类别转换重组的分子机制

基本信息

  • 批准号:
    7995253
  • 负责人:
  • 金额:
    $ 42.23万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-12-15 至 2013-11-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This application proposes studies of the mechanisms of immunoglobulin heavy chain (IgH) class switch recombination (CSR) and Somatic Hypermutation (SHM). We have shown that Activation Induced Cytidine Deaminase (AID), the initiator of CSR, is a single strand DNA (ssDNA) specific cytidine deaminase and we employed a series of novel biochemical and genetic approaches to elucidate mechanisms by which AID gains access to transcribed double strand (ds)DNA sequences in the context transcription-generated ssDNA structures and/or certain AID modifications or co-factors. We also showed that CSR may employ general processes for synapsis of AID-initiated DNA double strand breaks (DSBs), that general DNA repair factors function in CSR, and that two distinct end-joining pathways fuse S region breaks to complete CSR. Our current proposal builds on these observations in the context of three specific Aims. Our first aim proposes use of biochemical and genetic approaches to elucidate basic mechanisms of AID function and regulation. In this regard, we developed methods to purify AID from normal B cells, in vitro assays for transcription-dependent AID deamination of dsDNA DNA, and genetic approaches to evaluate in vivo AID functions elucidated biochemically. Our second aim addresses mechanisms by which DNA sequences influence AID activity and its outcome. For these studies, we developed targeted mutation assays to replace endogenous IgH class switch (S) regions and exons encoding IgH variable regions with test sequences that will allow us to determine how substrate sequences influence activities of AID and other relevant factors in CSR and SHM. Together, the complementary biochemical and genetic assays of Aims 1 and 2 offer a powerful approach for elucidating factors and mechanisms involved in initiation and regulation of IgH CSR and SHM. A third proposed aim is to elucidate processes involved in the repair of AID induced DSBs to complete CSR. For these studies, we again have developed a large array of reagents and novel approaches, including cytogenetic methods to follow CSR related breaks in chromosomes, novel genetic approaches to study factors involved in long range synapsis of DSBs, and genetic models to elucidate DSB repair pathways that complete IgH CSR. Our proposed studies should provide novel insights into the mechanism of antibody production via IgH CSR and, therefore, be relevant to understanding immunodeficiencies, vaccine immunology, and autoimmune diseases. As CSR is required for IgE production, the work will also be relevant to understanding pathogenesis of allergic diseases and asthma. Finally, the work is relevant to B cell malignancies as they often involve chromosomal translocations that link translocated oncogenes to IgH S regions via aberrant CSR. PUBLIC HEALTH RELEVANCE: Our proposed studies will continue to provide novel insights into the mechanism by which different types of antibodies are produced through the gene rearrangement process termed immunoglobulin heavy chain class switch recombination (CSR). Elucidation of the CSR mechanism has great relevance for understanding immunodeficiency and autoimmune diseases. Elucidation of the CSR mechanism also has importance for fully understanding allergic diseases and asthma, as increased production of a particular class of antibodies is an important component of the pathogenesis of these diseases. Finally, the work will help elucidate factors that underlie certain cancers of the immune system, such as lymphomas, which activate cancer causing genes through aberrant CSR.
描述(由申请人提供):本申请提出了免疫球蛋白重链(IgH)类别转换重组(CSR)和体细胞超突变(SHM)机制的研究。我们已经表明,激活诱导的胞苷脱氨酶(AID),CSR的启动子,是一种单链DNA(ssDNA)特异性胞苷脱氨酶,我们采用了一系列新的生化和遗传学方法来阐明机制,AID获得的背景下转录产生的ssDNA结构和/或某些AID修饰或辅因子的转录双链(ds)DNA序列。我们还表明,CSR可能采用艾滋病引发的DNA双链断裂(DSB)的突触的一般过程,一般的DNA修复因子在CSR中的功能,以及两个不同的末端连接途径融合S区断裂完成CSR。我们目前的建议是在三个具体目标的范围内根据这些意见提出的。我们的第一个目标是利用生物化学和遗传学方法来阐明AID功能和调节的基本机制。在这方面,我们开发的方法,从正常的B细胞,在体外测定转录依赖性的双链DNA的AID脱氨基,和遗传方法,以评估在体内的AID功能阐明生物化学。我们的第二个目标是解决DNA序列影响AID活性及其结果的机制。对于这些研究,我们开发了靶向突变测定,以用测试序列替换内源性IgH类别转换(S)区和编码IgH可变区的外显子,这将使我们能够确定底物序列如何影响AID和CSR和SHM中其他相关因子的活性。总之,目标1和2的互补生化和遗传测定为阐明IgH CSR和SHM的启动和调节所涉及的因素和机制提供了强有力的方法。第三个目标是阐明AID诱导的DSB修复完成CSR的过程。对于这些研究,我们再次开发了大量的试剂和新的方法,包括细胞遗传学方法来跟踪染色体中CSR相关的断裂,新的遗传学方法来研究DSB长距离突触中涉及的因素,以及阐明完成IgH CSR的DSB修复途径的遗传模型。我们提出的研究应提供新的见解抗体生产的机制,通过IgH CSR,因此,有关了解免疫缺陷,疫苗免疫学,和自身免疫性疾病。由于CSR是IgE产生所必需的,这项工作也将与了解过敏性疾病和哮喘的发病机制有关。最后,这项工作是相关的B细胞恶性肿瘤,因为它们往往涉及染色体易位,连接易位的癌基因IgH S区通过异常的CSR。公共卫生关系:我们提出的研究将继续提供新的见解的机制,不同类型的抗体是通过基因重排过程中产生的免疫球蛋白重链类转换重组(CSR)。阐明CSR机制对于理解免疫缺陷和自身免疫性疾病具有重要意义。CSR机制的阐明对于充分理解过敏性疾病和哮喘也具有重要意义,因为特定类别抗体的产生增加是这些疾病发病机制的重要组成部分。最后,这项工作将有助于阐明免疫系统某些癌症的基础因素,如淋巴瘤,它通过异常的CSR激活致癌基因。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Frederick W. Alt其他文献

Case of mistaken identity
认错人的情况
  • DOI:
    10.1038/428029a
  • 发表时间:
    2004-03-04
  • 期刊:
  • 影响因子:
    48.500
  • 作者:
    Craig H. Bassing;Frederick W. Alt
  • 通讯作者:
    Frederick W. Alt
Activated Ras signals differentiation and expansion of CD4+8+ thymocytes.
激活的 Ras 发出 CD4 8 胸腺细胞分化和扩增的信号。
From the Cover: Abnormal development of Purkinje cells and lymphocytes in Atm mutant mice
封面图片:Atm 突变小鼠浦肯野细胞和淋巴细胞发育异常
  • DOI:
  • 发表时间:
    2000
  • 期刊:
  • 影响因子:
    0
  • 作者:
    P. Borghesani;Frederick W. Alt;Andrea Bottaro;L. Davidson;Saime Aksoy;Gary Rathbun;Thomas M. Roberts;Wojciech Swat;R. Segal;Yansong Gu
  • 通讯作者:
    Yansong Gu
RNA editing meets DNA shuffling
RNA 编辑与 DNA 改组相遇
  • DOI:
    10.1038/35024189
  • 发表时间:
    2000-09-07
  • 期刊:
  • 影响因子:
    48.500
  • 作者:
    Ming Tian;Frederick W. Alt
  • 通讯作者:
    Frederick W. Alt
Sirt3 Regulates Fatty Acid Oxidation via Reversible Enzyme Deacetylation Hhs Public Access Supplementary Material
Sirt3 通过可逆酶脱乙酰作用调节脂肪酸氧化 Hhs 公共访问补充材料
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
    M. Hirschey;Tadahiro Shimazu;E. Goetzman;Enxuan Jing;B. Schwer;David B. Lombard;Carrie A. Grueter;Charles Harris;S. Biddinger;O. Ilkayeva;Robert D. Stevens;Yu Li;A. Saha;N. Ruderman;J. Bain;C. Newgard;R. V. Farese;Frederick W. Alt;C. R. Kahn;E. Verdin
  • 通讯作者:
    E. Verdin

Frederick W. Alt的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Frederick W. Alt', 18)}}的其他基金

Role of DNA Double Strand Break Response in Suppression of Thymic Lymphoma
DNA 双链断裂反应在抑制胸腺淋巴瘤中的作用
  • 批准号:
    7780950
  • 财政年份:
    2010
  • 资助金额:
    $ 42.23万
  • 项目类别:
Mouse models of severe combined immunodeficiencies
严重联合免疫缺陷小鼠模型
  • 批准号:
    7614101
  • 财政年份:
    2009
  • 资助金额:
    $ 42.23万
  • 项目类别:
Mechanisms that Regulate Antibody Class Switch Recombination and Somatic Hypermutation
调节抗体类别转换重组和体细胞超突变的机制
  • 批准号:
    10392890
  • 财政年份:
    2008
  • 资助金额:
    $ 42.23万
  • 项目类别:
Molecular Mechanisms of Class Switch Recombination
类别转换重组的分子机制
  • 批准号:
    8386894
  • 财政年份:
    2008
  • 资助金额:
    $ 42.23万
  • 项目类别:
Molecular Mechanisms of Class Switch Recombination
类别转换重组的分子机制
  • 批准号:
    7743798
  • 财政年份:
    2008
  • 资助金额:
    $ 42.23万
  • 项目类别:
AID Targeting Mechanisms for IgH Switch Recombination and Somatic Hypermutation
IgH 开关重组和体细胞超突变的 AID 靶向机制
  • 批准号:
    9228317
  • 财政年份:
    2008
  • 资助金额:
    $ 42.23万
  • 项目类别:
Mechanisms that Regulate Antibody Class Switch Recombination and Somatic Hypermutation
调节抗体类别转换重组和体细胞超突变的机制
  • 批准号:
    10612752
  • 财政年份:
    2008
  • 资助金额:
    $ 42.23万
  • 项目类别:
Molecular Mechanisms of Class Switch Recombination
类别转换重组的分子机制
  • 批准号:
    7577240
  • 财政年份:
    2008
  • 资助金额:
    $ 42.23万
  • 项目类别:
Molecular Mechanisms of Class Switch Recombination
类别转换重组的分子机制
  • 批准号:
    8197214
  • 财政年份:
    2008
  • 资助金额:
    $ 42.23万
  • 项目类别:
AID Targeting Mechanisms for IgH Switch Recombination and Somatic Hypermutation
IgH 开关重组和体细胞超突变的 AID 靶向机制
  • 批准号:
    8697880
  • 财政年份:
    2008
  • 资助金额:
    $ 42.23万
  • 项目类别:

相似海外基金

Biosynthesis of bet-alanine in autolysosomes.
自溶酶体中 β-丙氨酸的生物合成。
  • 批准号:
    22K08681
  • 财政年份:
    2022
  • 资助金额:
    $ 42.23万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Understanding the metabolic consequences of the systemic alanine depletion in pancreatic ductal adenocarcinoma
了解胰腺导管腺癌中全身丙氨酸消耗的代谢后果
  • 批准号:
    474506
  • 财政年份:
    2022
  • 资助金额:
    $ 42.23万
  • 项目类别:
    Studentship Programs
Characterizing alanine transporters as therapeutic targets for pancreatic cancer
将丙氨酸转运蛋白描述为胰腺癌的治疗靶点
  • 批准号:
    466496
  • 财政年份:
    2021
  • 资助金额:
    $ 42.23万
  • 项目类别:
    Studentship Programs
Understanding the requirements of alanine supply and demand in pancreatic ductal adenocarcinoma
了解胰腺导管腺癌中丙氨酸的供需要求
  • 批准号:
    451838
  • 财政年份:
    2021
  • 资助金额:
    $ 42.23万
  • 项目类别:
    Operating Grants
Sensing living P. aeruginosa using D-alanine derived radiotracers
使用 D-丙氨酸衍生的放射性示踪剂感测活的铜绿假单胞菌
  • 批准号:
    10230924
  • 财政年份:
    2021
  • 资助金额:
    $ 42.23万
  • 项目类别:
Sensing living P. aeruginosa using D-alanine derived radiotracers
使用 D-丙氨酸衍生的放射性示踪剂感测活的铜绿假单胞菌
  • 批准号:
    10399593
  • 财政年份:
    2021
  • 资助金额:
    $ 42.23万
  • 项目类别:
Sensing living P. aeruginosa using D-alanine derived radiotracers
使用 D-丙氨酸衍生的放射性示踪剂感测活的铜绿假单胞菌
  • 批准号:
    10570987
  • 财政年份:
    2021
  • 资助金额:
    $ 42.23万
  • 项目类别:
Spot measurement of alanine radicals produced by irradiation and application of sugar radial to dosimeter
辐照产生的丙氨酸自由基的点测及糖自由基在剂量计中的应用
  • 批准号:
    19K05343
  • 财政年份:
    2019
  • 资助金额:
    $ 42.23万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Metabolic significance of lysosomal beta-alanine
溶酶体β-丙氨酸的代谢意义
  • 批准号:
    18K08528
  • 财政年份:
    2018
  • 资助金额:
    $ 42.23万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of dosimetry technique for IMRT using alanine dosimeter
使用丙氨酸剂量计开发 IMRT 剂量测定技术
  • 批准号:
    18K15615
  • 财政年份:
    2018
  • 资助金额:
    $ 42.23万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了